This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Dec;360(9350):2085-6; author reply 2086.

doi: 10.1016/S0140-6736(02)11982-9.

TARGET follow-up study

Raymond Hautvast, Gillian Jessurun, Rene Tio

PMID: 12504451
DOI: 10.1016/S0140-6736(02)11982-9

Comment

TARGET follow-up study

Raymond Hautvast et al. Lancet. 2002 Dec.

. 2002 Dec;360(9350):2085-6; author reply 2086.

doi: 10.1016/S0140-6736(02)11982-9.

Authors

Raymond Hautvast, Gillian Jessurun, Rene Tio

PMID: 12504451
DOI: 10.1016/S0140-6736(02)11982-9

No abstract available

PubMed Disclaimer

Comment on

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.
Moliterno DJ, Yakubov SJ, DiBattiste PM, Herrmann HC, Stone GW, Macaya C, Neumann FJ, Ardissino D, Bassand JP, Borzi L, Yeung AC, Harris KA, Demopoulos LA, Topol EJ; TARGET investigators. Moliterno DJ, et al. Lancet. 2002 Aug 3;360(9330):355-60. doi: 10.1016/S0140-6736(02)09605-8. Lancet. 2002. PMID: 12241774 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information